Leen Kawas is an entrepreneur and investor known for being the executive of Propel. She holds a PhD. She can be followed on several social media outlets such as LinkedIn, Twitter, and Forbes. Leen Kawas also runs her own blog on Medium. Before leading Propel, she held the position at Athira Pharma, raising an excess of $400 million under her guidance and stewardship. Kawas holds many skills related in the pharmaceutical industry and general life sciences. The entrepreneur also knows how to lead successful companies, winning awards in various magazines and publications such as Endpoints, Biospace, Geek Wire, and many more for her leadership.
She was even named as being one of the most influential people of Seattle from Seattle Magazine and published as a woman to watch in the area of life sciences by Washington Biotechnology and the Biomedical Association back in 2015. The entrepreneur has won an excess of 10+ awards for her influence, business expertise, leadership, Endpoints Under 40, a life science achievement award, coin award winner, startup CEO of the year from GeekWire, Entrepreneur of the Year recognition as a finalist a couple of times. Leen Kawas main role is as a Managing General Partner according to the biography page from Propel. The leader is on many boards with the Life Science Washington Board, Scientific Review Board for the Alzheimer’s Drug Foundation, and their associate Washington Chapter Board. Kawas is an advocate for female entrepreneurship and female scientists. The investor is also a part of the Springboard Network. Propel Bio Partners is backed by their phrase – Innovation in Motion.
Learn more about Leen Kawas : https://www.propelbio.com/team/leen-kawas-phd/